MC Trio股票緩衝主動型ETF TRIO 深 滬
已收盤 04-02 16:00:00 美东时间
60.7861
+0.057
+0.09%
華盛通- 最 高60.79
- 今 開60.79
- 成交量 266股
- 最 低 60.7861
- 昨 收 60.7293
- 總市值 1.12亿
- 52周最高 62.1688
- 市盈率 靜 --
- 換手率 0.01%
- 52周最低 50.1565
- 委 比 0.00%
- 總股本 184.00万
- 歷史最高 62.1688
- 量 比 0.52
- 振 幅 0.01%
- 歷史最低 48.6048
- 每 手 1
- 風險率 3.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Trio Petroleum Corp - Files Amendment No. 5 To Prospectus Supplement On March 30, 2026
BRIEF-Trio Petroleum Corp - Files Amendment No. 5 To Prospectus Supplement On March 30, 2026 March 30 (Reuters) - Trio Petroleum Corp TPET.A : TRIO PETROLEUM CORP - FILES AMENDMENT NO. 5 TO PROSPECTUS SUPPLEMENT ON MARCH 30, 2026 - SEC FILING TRIO PETROLEUM CORP - AFTER AMENDMENT NO. 5, $1,010,000 O
03-30 22:08
BRIEF-Trio-Tech International Secures $5.3 Million Order For Burn-In Boards Supporting Next-Generation Ai Gpu Platform
BRIEF-Trio-Tech International Secures $5.3 Million Order For Burn-In Boards Supporting Next-Generation Ai Gpu Platform March 17 (Reuters) - Trio-Tech International TRT.A : TRIO-TECH INTERNATIONAL SECURES $5.3 MILLION ORDER FOR BURN-IN BOARDS SUPPORTING NEXT-GENERATION AI GPU PLATFORM TRIO-TECH INTER
03-17 20:40
BRIEF-Celltrion Announces U.S. Availability Of Avtozma® (Tocilizumab-Anoh) Subcutaneous (SC) Formulation
BRIEF-Celltrion Announces U.S. Availability Of Avtozma® (Tocilizumab-Anoh) Subcutaneous (SC) Formulation March 16 (Reuters) - Celltrion Inc 068270.KS : CELLTRION ANNOUNCES U.S. AVAILABILITY OF AVTOZMA® (TOCILIZUMAB-ANOH) SUBCUTANEOUS (SC) FORMULATION Source text: ID:nPnb3W0S9a Further company covera
03-16 20:16
BRIEF-Trio-Tech International - Secures Initial Production Order Valued At $2.5 Million For Burn-In Services
BRIEF-Trio-Tech International - Secures Initial Production Order Valued At $2.5 Million For Burn-In Services March 4 (Reuters) - Trio-Tech International TRT.A : TRIO-TECH INTERNATIONAL - SECURES INITIAL PRODUCTION ORDER VALUED AT $2.5 MILLION FOR BURN-IN SERVICES Source text: ID:nBw4GyFPRa Further c
03-04 21:30
Glaukos Publishes Investor Presentation on Interventional Glaucoma and Keratoconus Therapies
Glaukos Publishes Investor Presentation on Interventional Glaucoma and Keratoconus Therapies Glaukos Corporation released an investor presentation outlining its focus on interventional glaucoma and interventional keratoconus. The company highlighted its commercial portfolio and pipeline, including i
03-02 20:23
Artivion Reports Strong Survival and Low Morbidity in NEXUS TRIOMPHE and AMDS PERSEVERE Trials
Artivion Reports Strong Survival and Low Morbidity in NEXUS TRIOMPHE and AMDS PERSEVERE Trials Artivion Inc. has announced the presentation of new clinical data from two trials—the NEXUS TRIOMPHE IDE trial and the AMDS PERSEVERE IDE trial—at the 62nd Annual Meeting of the Society of Thoracic Surgeon
02-02 21:01
BRIEF-Patriot National Bancorp Inc - On Dec 18, Steven Grunblatt, Evp And Cio, Passed Away - SEC Filing
Dec 22 (Reuters) - Patriot National Bancorp Inc PNBK.O: PATRIOT NATIONAL BANCORP INC - ON DEC 18, STEVEN GRUNBLATT, EVP AND CIO, PASSED AWAY - SEC FILING Source text: [ID:n0001437749-25-038571] Furthe...
2025-12-23 07:02
BRIEF-Trio-Tech International Announces 2-For-1 Forward Stock Split
Dec 19 (Reuters) - Trio-Tech International TRT.A: TRIO-TECH INTERNATIONAL ANNOUNCES 2-FOR-1 FORWARD STOCK SPLIT Source text: ID:nBws5z24a Further company coverage: TRT.A ((Reuters.Briefs@thomsonreuter...
2025-12-19 22:34
BRIEF-RTX Says Raytheon Awarded $168 Million Contract For Romanian Patriot Air Defense Equipment
Dec 19 (Reuters) - Rtx Corp RTX.N: RTX'S RAYTHEON AWARDED $168 MILLION CONTRACT FOR ROMANIAN PATRIOT AIR DEFENSE EQUIPMENT Source text: ID:nPn7y7984a Further company coverage: RTX.N ((Reuters.Briefs@t...
2025-12-19 16:00
BRIEF-Trio-Tech International Buys 50% Equity In Trio-Tech Malaysia - SEC FILING
Dec 5 (Reuters) - Trio-Tech International TRT.A: TRIO-TECH INTERNATIONAL - ON DEC 3, UNIT BUYS 50% EQUITY INTEREST IN TRIO-TECH MALAYSIA - SEC FILING TRIO-TECH INTERNATIONAL - TRIO-TECH SINGAPORE IS W...
2025-12-05 22:03
